Resonant Clinical Solutions Acquires Labfish and Its U.S. and U.K. Affiliates

Cerebral Acquires Resilience Lab

August 7, 2025

Healthcare Services

Cerebral, a virtual mental health provider, has acquired Resilience Lab to integrate Resilience Lab’s clinician development platform and outcomes-focused care model into Cerebral’s nationwide virtual care offering. The acquisition aims to scale Resilience Lab’s training, certification and measurement-informed care to expand clinician capacity and improve consistency and quality across Cerebral’s integrated therapy and psychiatry services.

Audax Private Equity Acquires Avantor's Clinical Services Business, Rebrands as Resonant Clinical Solutions

October 18, 2024

Healthcare Services

Audax Private Equity completed the acquisition of Avantor, Inc.'s Clinical Services business for approximately $650 million. The business has been rebranded as Resonant Clinical Solutions and is positioned as an independent platform in outsourced clinical trial services.

Resonant Clinical Solutions Acquires Creapharm Bioservices from Myonex

May 2, 2024

Healthcare Services

Resonant Clinical Solutions acquired France-based Creapharm Bioservices from Myonex. The deal expands Resonant’s European biorepository and cryogenic storage capabilities for advanced therapies, including cell and gene therapy programs.

AccelLAB Management Acquires AccelLAB from Charles River Laboratories

January 18, 2024

Medical Devices

Key members of AccelLAB's management team acquired AccelLAB from Charles River Laboratories, and the business will operate independently as a standalone preclinical CRO serving the medical device and biologics markets. Fairmount Partners served as exclusive financial advisor to Charles River in the divestiture; AccelLAB employs approximately 100 staff across facilities in Boisbriand and Terrebonne, Quebec, Canada.

Calibre Scientific Acquires Labtech International Ltd

January 17, 2024

Medical Devices

Calibre Scientific has acquired Labtech International Ltd, a UK-based supplier and service provider of life science instruments, microscopy equipment, consumables and technical services. The acquisition expands Calibre Scientific's analytical instrument and service capabilities across the British Isles, strengthening its product offering and local service footprint for customers in biotechnology, diagnostics, education, environmental and pharmaceutical markets.

Eurofins Scientific Acquires Genetic Lab Co.,Ltd. (G Lab) in Japan

December 10, 2021

Healthcare Services

Eurofins Scientific has entered into a share purchase agreement to acquire Genetic Lab Co.,Ltd. (“G Lab”), a molecular biology-based testing provider in Japan. The acquisition is intended to strengthen Eurofins’ expansion in Asia and enhance its clinical and genetic testing capabilities, including COVID-19 PCR testing and biomarker development support for drug discovery and companion drugs.